Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 14/20 | 0.60 |
| ▸ | MME | P08473 | 2/20 | 0.52 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | CPA1 | P15085 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | BACE1 | P56817 | 2/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.49 |
| ▸ | FNTB | P49356 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31134428 | 0.94 | CTSD (0.60) | CTSDBACE1 | |
| SCHEMBL30455239 | 0.92 | CTSD (0.57) | CTSDBACE1 | |
| SCHEMBL30051590 | 0.90 | ACE (0.64) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL3202596 | 0.89 | CTSD (0.64) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL30050940 | 0.89 | CTSD (0.64) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL30052924 | 0.89 | CTSD (0.64) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL31590754 | 0.88 | MME (0.52) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL31042838 | 0.87 | CTSD (0.60) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL29732087 | 0.87 | CTSD (0.60) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL30311017 | 0.87 | MME (0.57) | CTSDMMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023120844-A1 | COMPOSITION FOR MASS PROLIFERATING NATURAL KILLER CELLS, COMPRISING NOVEL PEPTIDE, AND METHOD FOR MASS PROLIFERATING NATURAL KILLER CELLS BY USING SAME | 엔케이젠 주식회사 | 2023-06-29 | — | — | WO | disclosed |